Medical oncology

131 – 140 of 626

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1000463?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
13
14
15
16
…
63
next »

2022
Mark Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Wang, Michael L. ; Jurczak, Wojciech ; Jerkeman, Mats ^LU ; Trotman, Judith ; Zinzani, Pier L. ; Belada, David ; Boccomini, Carola ; Flinn, Ian W. ; Giri, Pratyush and Goy, Andre , et al. (2022) In New England Journal of Medicine 386(26). p.2482-2494
- Contribution to journal › Article
Mark Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission
Ekberg, Sara ; Crowther, Michael ; Harrysson, Sara ; Jerkeman, Mats ^LU ; E. Smedby, Karin and Eloranta, Sandra (2022) In British Journal of Cancer 127(9). p.1642-1649
- Contribution to journal › Article
Mark Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
Lokhande, Lavanya ^LU ; Kuci Emruli, Venera ^LU ; Eskelund, Christian Winther ; Kolstad, Arne ; Hutchings, Martin ; Räty, Riikka ; Niemann, Carsten Utoft ; Grønbæk, Kirsten ; Jerkeman, Mats ^LU and Ek, Sara ^LU (2022) In Cancer Reports 5(7).
- Contribution to journal › Article
Mark Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017
Albertsson Lindblad, Alexandra ^LU ; Palsdottir, Thorgerdur ; Smedby, Karin E ; Weibull, Caroline E ; Glimelius, Ingrid and Jerkeman, Mats ^LU (2022) In Haematologica 107(3). p.740-743
- Contribution to journal › Letter
Mark Time Trends for Incidence and Net Survival of Cervical Cancer in Sweden 1960-2014 - A Nationwide Population-Based Study
Sundqvist, Avalon ^LU ; Moberg, Louise ^LU ; Dickman, Paul W. ; Högberg, Thomas ^LU and Borgfeldt, Christer ^LU (2022) In Cancer Epidemiology Biomarkers and Prevention 31(8). p.1572-1581
- Contribution to journal › Article
Mark The EHA Research Roadmap: Malignant Lymphoid Diseases
Dreyling, M. ; Jerkeman, M. ^LU and Salles, G. (2022) In HemaSphere 6(6). p.726-726
- Contribution to journal › Article
Mark SELNET clinical practice guidelines for bone sarcoma
Blay, J.Y. ; Eriksson, M. ^LU and Martin-Broto, Javier (2022) In Critical Reviews in Oncology/Hematology 174.
- Contribution to journal › Article
Mark Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors
Ekedahl, Henrik ^LU ; Isaksson, Sigrid ^LU ; Ståhl, Olof ^LU ; Bogefors, Karolina ^LU ; Romerius, Patrik ^LU ; Eberhard, Jakob ^LU and Giwercman, Aleksander ^LU (2022) In BMC Cancer 22. p.1-11
- Contribution to journal › Article
Mark Idelalisib in relapsed/refractory diffuse large B-cell lymphoma : results from a Nordic Lymphoma Group phase II trial
Fjordén, Karin ^LU ; Ekberg, Sara ; Kuric, Nevzeta ; Smedby, Karin E. ; Lagerlöf, Ingemar ; Larsen, Thomas S. ; Jørgensen, Judit M. ; de Nully Brown, Peter and Jerkeman, Mats ^LU (2022) In British Journal of Haematology 196(2). p.437-440
- Contribution to journal › Letter
Mark Epidemiological and clinical aspects of T-cell lymphoma
Cederleuf, Henrik ^LU (2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)

« previous
1
…
13
14
15
16
…
63
next »